Life Sciences & Healthcare
Rapid transformation in the Life Sciences & Healthcare industry requires organisations to strike a balance between market potential, policy compliance and patient demands with continued innovation.
We are all affected by this sector and it falls under heavy social and political scrutiny. Regulation of competition in the sector has also made it increasingly dynamic and challenging. As the demand for life sciences and healthcare services is ever-growing, so too are the strains and scrutiny placed on its decision makers.
With the largest Life Sciences & Healthcare Team in de Dutch market, we can relate to our clients and deliver top tier services to our clients during all the stages of business lifecycle.

Good ‘climate’
Recent changes in the Dutch healthcare system have allowed investors and care providers to operate from the Netherlands when deploying innovative care concepts. The relocation of the EMA to Amsterdam attracts also new pharmaceutical companies and generates a lot of activity.
Remodelling of the healthcare system has resulted in hospital mergers, partnerships, and reorganisation of healthcare. Besides that, E-Health plays an increased role in prevention and screening. This growth in innovation is evident across other Loyens & Loeff markets in Belgium, Switzerland and Luxembourg.
Product development in the pharma industry
Successfully developing and marketing products in the pharmaceutical and life sciences sectors requires first-rate legal and tax support. This support must include an expert understanding of clinical research, intellectual property, tax planning, regulatory compliance, and pricing issues.
Staying up to date

Life Sciences LinkedIn page
